In Depth 18 Nov 2024What is Abcam’s founder, Jonathan Milner, up to? Since Abcam was acquired in December 2023, its founder, Jonathan Milner has been very active. Delve into his investment strategy. November 18, 2024 - 17 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Expert Advice 15 Nov 2024How biotech startups become unicorns Delve into what differentiates a successful biotech startup from a unicorn reaching a $1 billion valuation. November 15, 2024 - 10 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Podcast 15 Nov 2024Beyond profits: The Bill & Melinda Gates MRI’s mission to combat neglected diseases This week, our guest is Dr Claire Wagner, head of corporate strategy and market access at the Bill & Melinda Gates Medical Research Institute (Gates MRI). November 15, 2024 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
In Depth 11 Nov 2024Gene editing sector investment struggles: What’s driving the slowdown? Find out what is driving the slowdown in gene therapy investment, as the sector continues to struggle with widespread layoffs. November 11, 2024 - 8 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 7 Nov 2024The biggest private biotech investments in October 2024 The companies Treeline Biosciences, Kailera Therapeutics, and Seaport Therapeutics bagged the biggest private biotech investments in October 2024. November 7, 2024 - 3 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 5 Nov 2024From consumer health to pure biopharma: Inside Sanofi’s strategic shift Delve into Sanofi’s “play to win” strategy as investments are ramping up after their consumer health division’s divestment. November 5, 2024 - 9 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 4 Oct 2024The biggest private biotech investments in September 2024 The companies Candid Therapeutics, ArsenalBio, and eGenesis bagged the biggest private biotech investments in September 2024. October 4, 2024 - 3 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 12 Sep 2024Biotech R&D crunch: The impact of the Inflation Reduction Act and economic challenges Delve into the consequences of the Inflation Reduction Act and the broader economic conditions on biotech R&D. September 12, 2024 - 7 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 5 Sep 2024The biggest private biotech investments in August 2024 The companies Borealis Biosciences, Outpace Bio, and Halda Therapeutics bagged the biggest private biotech investments in August 2024. September 5, 2024 - 3 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Podcast 16 Aug 2024Challenging the European biotech funding status quo Explore the latest trends in biotech investments and funding strategies in Europe with insights from 4BIO Capital’s Dima Kuzmin. August 16, 2024 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
In Depth 6 Aug 2024The biggest private biotech investments in July 2024 The companies Cardurion Pharmaceuticals, Beacon Therapeutics, and Third Arc Bio bagged the biggest private biotech investments in July 2024. August 6, 2024 - 3 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 30 Jul 2024Why is the immunology and inflammation market suddenly attracting a wave of investment? Discover why the immunology and inflammation market has recently been attracting a major wave of investment. July 30, 2024 - 13 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email